Clinical trial
Effect of Indomethacin on the Progression of Alzheimer's Disease
NCT00432081 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00432081 |
|---|---|
| Title | Effect of Indomethacin on the Progression of Alzheimer's Disease |
| Official title | Effect of Indomethacin on the Progression of Alzheimer's Disease |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | American Health Assistance Foundation Netherlands Brain Foundation Netherlands Alzheimer Foundation |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | indomethacin |
| Enrollment | 160 |
| Start date | May 1, 2000 |
| Completion | Aug 1, 2005 |
| First posted | Feb 6, 2007 |
| Last update posted | Feb 6, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: